| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Catheterization | 74 | 2025 | 632 | 11.590 |
Why?
|
| Ductus Arteriosus, Patent | 26 | 2023 | 143 | 9.320 |
Why?
|
| Pulmonary Valve | 22 | 2024 | 92 | 5.650 |
Why?
|
| Heart Septal Defects, Atrial | 14 | 2024 | 118 | 5.400 |
Why?
|
| Septal Occluder Device | 12 | 2024 | 42 | 4.740 |
Why?
|
| Stents | 37 | 2024 | 835 | 4.510 |
Why?
|
| Ductus Arteriosus | 13 | 2024 | 62 | 4.330 |
Why?
|
| Pulmonary Artery | 29 | 2024 | 438 | 4.220 |
Why?
|
| Blalock-Taussig Procedure | 14 | 2023 | 51 | 4.130 |
Why?
|
| Heart Valve Prosthesis Implantation | 22 | 2024 | 437 | 3.900 |
Why?
|
| Heart Defects, Congenital | 36 | 2024 | 1830 | 3.610 |
Why?
|
| Heart Valve Prosthesis | 18 | 2024 | 302 | 3.400 |
Why?
|
| Palliative Care | 18 | 2023 | 433 | 3.170 |
Why?
|
| Tetralogy of Fallot | 14 | 2024 | 164 | 3.060 |
Why?
|
| Pulmonary Circulation | 16 | 2023 | 121 | 2.930 |
Why?
|
| Treatment Outcome | 103 | 2024 | 12305 | 2.710 |
Why?
|
| Coronary Angiography | 19 | 2024 | 449 | 2.520 |
Why?
|
| Coronary Vessel Anomalies | 16 | 2023 | 282 | 2.520 |
Why?
|
| Prosthesis Design | 25 | 2024 | 668 | 2.420 |
Why?
|
| Pulmonary Valve Insufficiency | 8 | 2024 | 41 | 2.350 |
Why?
|
| Heart-Assist Devices | 10 | 2022 | 1027 | 2.220 |
Why?
|
| Pulmonary Veins | 10 | 2024 | 161 | 2.170 |
Why?
|
| Cardiac Surgical Procedures | 18 | 2024 | 1123 | 1.940 |
Why?
|
| Vascular Fistula | 4 | 2021 | 31 | 1.920 |
Why?
|
| Ventricular Function, Right | 4 | 2020 | 113 | 1.900 |
Why?
|
| Coronary Vessels | 12 | 2023 | 531 | 1.840 |
Why?
|
| Prosthesis Implantation | 4 | 2020 | 140 | 1.810 |
Why?
|
| Retrospective Studies | 92 | 2024 | 16362 | 1.800 |
Why?
|
| Infant, Newborn | 60 | 2024 | 8272 | 1.790 |
Why?
|
| Ultrasonography, Interventional | 7 | 2019 | 189 | 1.790 |
Why?
|
| Heart Ventricles | 15 | 2024 | 782 | 1.700 |
Why?
|
| Fractional Flow Reserve, Myocardial | 6 | 2021 | 44 | 1.700 |
Why?
|
| Humans | 185 | 2025 | 125466 | 1.550 |
Why?
|
| Aorta, Thoracic | 8 | 2021 | 526 | 1.500 |
Why?
|
| Infant | 56 | 2025 | 12601 | 1.420 |
Why?
|
| Pulmonary Atresia | 10 | 2024 | 47 | 1.400 |
Why?
|
| Hemodynamics | 21 | 2024 | 851 | 1.380 |
Why?
|
| Heart Failure | 9 | 2022 | 2299 | 1.380 |
Why?
|
| Hypertension, Pulmonary | 5 | 2025 | 439 | 1.320 |
Why?
|
| Embolization, Therapeutic | 3 | 2023 | 216 | 1.300 |
Why?
|
| Bioprosthesis | 6 | 2024 | 111 | 1.290 |
Why?
|
| Time Factors | 35 | 2024 | 6323 | 1.280 |
Why?
|
| Child | 80 | 2025 | 24607 | 1.280 |
Why?
|
| Aorta | 11 | 2023 | 545 | 1.240 |
Why?
|
| Catheterization, Peripheral | 6 | 2019 | 124 | 1.220 |
Why?
|
| Coronary Artery Disease | 6 | 2023 | 805 | 1.210 |
Why?
|
| Child, Preschool | 51 | 2025 | 14143 | 1.200 |
Why?
|
| Postoperative Complications | 14 | 2021 | 3055 | 1.180 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 76 | 1.170 |
Why?
|
| Adolescent | 62 | 2024 | 19448 | 1.160 |
Why?
|
| Atrial Fibrillation | 5 | 2024 | 657 | 1.150 |
Why?
|
| Female | 99 | 2025 | 66904 | 1.140 |
Why?
|
| Ventricular Function, Left | 4 | 2022 | 514 | 1.140 |
Why?
|
| Scimitar Syndrome | 4 | 2021 | 52 | 1.120 |
Why?
|
| Aortic Coarctation | 3 | 2023 | 110 | 1.110 |
Why?
|
| Device Removal | 5 | 2024 | 218 | 1.110 |
Why?
|
| Male | 98 | 2025 | 61637 | 1.080 |
Why?
|
| Thrombosis | 5 | 2019 | 524 | 1.060 |
Why?
|
| Stenosis, Pulmonary Vein | 3 | 2024 | 19 | 1.050 |
Why?
|
| Body Weight | 3 | 2021 | 989 | 1.030 |
Why?
|
| Catheterization, Central Venous | 3 | 2014 | 130 | 1.010 |
Why?
|
| Foramen Ovale, Patent | 4 | 2021 | 19 | 0.990 |
Why?
|
| Drug-Eluting Stents | 3 | 2021 | 63 | 0.940 |
Why?
|
| Echocardiography | 15 | 2024 | 1066 | 0.930 |
Why?
|
| Angioplasty, Balloon | 7 | 2024 | 155 | 0.930 |
Why?
|
| Reoperation | 11 | 2022 | 830 | 0.920 |
Why?
|
| Hypoplastic Left Heart Syndrome | 5 | 2022 | 257 | 0.900 |
Why?
|
| Prosthesis Failure | 6 | 2024 | 156 | 0.890 |
Why?
|
| Young Adult | 32 | 2024 | 9086 | 0.860 |
Why?
|
| Aneurysm, False | 2 | 2023 | 93 | 0.850 |
Why?
|
| Atrial Appendage | 1 | 2024 | 46 | 0.850 |
Why?
|
| Computed Tomography Angiography | 7 | 2024 | 198 | 0.840 |
Why?
|
| Diverticulum | 1 | 2023 | 29 | 0.830 |
Why?
|
| Catheter Ablation | 4 | 2017 | 233 | 0.830 |
Why?
|
| Heart Aneurysm | 1 | 2023 | 37 | 0.830 |
Why?
|
| Cyanosis | 3 | 2021 | 42 | 0.830 |
Why?
|
| Fetal Heart | 1 | 2024 | 120 | 0.820 |
Why?
|
| Dyspnea | 4 | 2019 | 153 | 0.800 |
Why?
|
| Constriction, Pathologic | 4 | 2022 | 236 | 0.800 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2019 | 124 | 0.790 |
Why?
|
| Registries | 9 | 2024 | 1434 | 0.760 |
Why?
|
| Myocardial Bridging | 2 | 2024 | 12 | 0.760 |
Why?
|
| Heart Atria | 5 | 2020 | 320 | 0.730 |
Why?
|
| Patient Selection | 4 | 2024 | 697 | 0.720 |
Why?
|
| Clinical Decision-Making | 4 | 2024 | 263 | 0.690 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2021 | 90 | 0.690 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2018 | 40 | 0.680 |
Why?
|
| Coronary Stenosis | 2 | 2021 | 77 | 0.680 |
Why?
|
| Vascular Access Devices | 2 | 2017 | 33 | 0.670 |
Why?
|
| Predictive Value of Tests | 11 | 2024 | 2184 | 0.660 |
Why?
|
| Balloon Valvuloplasty | 3 | 2020 | 25 | 0.660 |
Why?
|
| Recovery of Function | 10 | 2024 | 443 | 0.660 |
Why?
|
| Blood Flow Velocity | 3 | 2019 | 456 | 0.650 |
Why?
|
| Adult | 44 | 2024 | 29642 | 0.640 |
Why?
|
| Pulsatile Flow | 1 | 2019 | 127 | 0.640 |
Why?
|
| Thrombectomy | 2 | 2019 | 93 | 0.630 |
Why?
|
| Hospitals, Pediatric | 3 | 2018 | 766 | 0.630 |
Why?
|
| Catheterization | 3 | 2022 | 227 | 0.630 |
Why?
|
| Thulium | 1 | 2019 | 6 | 0.630 |
Why?
|
| Everolimus | 1 | 2019 | 50 | 0.630 |
Why?
|
| United States | 24 | 2025 | 10926 | 0.630 |
Why?
|
| Body Height | 2 | 2019 | 216 | 0.630 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2020 | 180 | 0.620 |
Why?
|
| Neonatologists | 1 | 2019 | 20 | 0.610 |
Why?
|
| Cardiologists | 1 | 2019 | 20 | 0.610 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2019 | 38 | 0.600 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 139 | 0.600 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2018 | 12 | 0.590 |
Why?
|
| Vasodilator Agents | 1 | 2019 | 202 | 0.590 |
Why?
|
| Disease Management | 2 | 2019 | 532 | 0.570 |
Why?
|
| Kartagener Syndrome | 1 | 2017 | 13 | 0.570 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 115 | 0.560 |
Why?
|
| Venous Thrombosis | 2 | 2017 | 167 | 0.560 |
Why?
|
| Follow-Up Studies | 18 | 2022 | 5174 | 0.560 |
Why?
|
| Ventricular Outflow Obstruction | 5 | 2024 | 87 | 0.560 |
Why?
|
| Norwood Procedures | 4 | 2022 | 101 | 0.550 |
Why?
|
| Feasibility Studies | 10 | 2024 | 762 | 0.550 |
Why?
|
| Shock, Cardiogenic | 2 | 2022 | 193 | 0.550 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 184 | 0.550 |
Why?
|
| Risk Factors | 24 | 2024 | 10301 | 0.540 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 200 | 0.540 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2017 | 61 | 0.530 |
Why?
|
| Foreign-Body Migration | 1 | 2017 | 71 | 0.530 |
Why?
|
| Forecasting | 2 | 2018 | 352 | 0.530 |
Why?
|
| Endovascular Procedures | 7 | 2024 | 726 | 0.520 |
Why?
|
| Fontan Procedure | 5 | 2023 | 183 | 0.510 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2017 | 73 | 0.510 |
Why?
|
| Myocardial Ischemia | 4 | 2023 | 345 | 0.510 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 85 | 0.510 |
Why?
|
| Infant, Extremely Premature | 1 | 2016 | 87 | 0.500 |
Why?
|
| Angiography | 7 | 2024 | 210 | 0.490 |
Why?
|
| Texas | 11 | 2020 | 3583 | 0.460 |
Why?
|
| Age Factors | 11 | 2022 | 2828 | 0.450 |
Why?
|
| Catheters, Indwelling | 2 | 2013 | 153 | 0.440 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2024 | 259 | 0.430 |
Why?
|
| Vascular Surgical Procedures | 7 | 2022 | 554 | 0.430 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 3743 | 0.420 |
Why?
|
| Equipment Design | 5 | 2019 | 589 | 0.410 |
Why?
|
| Brachiocephalic Veins | 1 | 2012 | 13 | 0.410 |
Why?
|
| Chylothorax | 1 | 2013 | 27 | 0.410 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2013 | 19 | 0.410 |
Why?
|
| Venae Cavae | 1 | 2012 | 11 | 0.410 |
Why?
|
| Coronary Circulation | 6 | 2022 | 211 | 0.400 |
Why?
|
| Pericardial Effusion | 1 | 2013 | 63 | 0.400 |
Why?
|
| Central Venous Catheters | 1 | 2013 | 40 | 0.400 |
Why?
|
| Tricuspid Valve | 2 | 2024 | 61 | 0.390 |
Why?
|
| Europe | 3 | 2024 | 359 | 0.380 |
Why?
|
| Prospective Studies | 12 | 2025 | 6174 | 0.360 |
Why?
|
| Primary Health Care | 1 | 2017 | 774 | 0.360 |
Why?
|
| Myocardial Perfusion Imaging | 5 | 2024 | 56 | 0.340 |
Why?
|
| Diagnosis, Differential | 4 | 2023 | 1900 | 0.340 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2020 | 617 | 0.340 |
Why?
|
| Ventricular Septum | 2 | 2022 | 16 | 0.340 |
Why?
|
| Lung | 3 | 2021 | 1487 | 0.340 |
Why?
|
| Carotid Artery, Common | 2 | 2021 | 68 | 0.340 |
Why?
|
| Asthma | 1 | 2017 | 756 | 0.330 |
Why?
|
| Carotid Arteries | 2 | 2021 | 145 | 0.330 |
Why?
|
| Middle Aged | 25 | 2024 | 26833 | 0.330 |
Why?
|
| Stenosis, Pulmonary Artery | 2 | 2020 | 5 | 0.330 |
Why?
|
| Abnormalities, Multiple | 5 | 2024 | 960 | 0.320 |
Why?
|
| Axillary Artery | 2 | 2019 | 28 | 0.320 |
Why?
|
| Pulmonary Embolism | 2 | 2024 | 173 | 0.320 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 2 | 2013 | 27 | 0.310 |
Why?
|
| Vascular Patency | 6 | 2020 | 192 | 0.300 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2009 | 164 | 0.300 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2020 | 63 | 0.300 |
Why?
|
| Echocardiography, Doppler, Color | 5 | 2017 | 112 | 0.290 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2023 | 248 | 0.290 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1714 | 0.290 |
Why?
|
| Angioplasty | 2 | 2020 | 77 | 0.290 |
Why?
|
| Mitral Valve | 1 | 2009 | 252 | 0.280 |
Why?
|
| Survival Rate | 7 | 2019 | 2050 | 0.280 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2024 | 972 | 0.280 |
Why?
|
| Heart Transplantation | 3 | 2022 | 859 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2024 | 2093 | 0.270 |
Why?
|
| Risk Assessment | 8 | 2024 | 3440 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 3603 | 0.260 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2019 | 199 | 0.250 |
Why?
|
| Transposition of Great Vessels | 3 | 2020 | 132 | 0.250 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2019 | 147 | 0.250 |
Why?
|
| Incidence | 5 | 2022 | 3136 | 0.250 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2024 | 459 | 0.240 |
Why?
|
| Models, Cardiovascular | 2 | 2024 | 185 | 0.240 |
Why?
|
| Ultrasonography, Doppler | 2 | 2019 | 193 | 0.240 |
Why?
|
| Skin Pigmentation | 1 | 2025 | 27 | 0.240 |
Why?
|
| Cohort Studies | 6 | 2024 | 4843 | 0.240 |
Why?
|
| Pregnancy | 6 | 2024 | 7225 | 0.240 |
Why?
|
| Splenic Vein | 1 | 2024 | 10 | 0.230 |
Why?
|
| Hepatic Veins | 1 | 2024 | 22 | 0.230 |
Why?
|
| Hospital Mortality | 3 | 2020 | 1027 | 0.230 |
Why?
|
| Vascular Closure Devices | 1 | 2024 | 14 | 0.230 |
Why?
|
| Exercise | 2 | 2021 | 816 | 0.230 |
Why?
|
| Endocarditis | 3 | 2022 | 106 | 0.230 |
Why?
|
| Patient-Specific Modeling | 1 | 2024 | 8 | 0.230 |
Why?
|
| Finite Element Analysis | 1 | 2024 | 28 | 0.220 |
Why?
|
| Decompression, Surgical | 3 | 2019 | 94 | 0.220 |
Why?
|
| Data Accuracy | 2 | 2021 | 25 | 0.220 |
Why?
|
| Oximetry | 1 | 2025 | 171 | 0.220 |
Why?
|
| Aortic Valve | 3 | 2020 | 445 | 0.210 |
Why?
|
| Health Information Systems | 1 | 2023 | 31 | 0.210 |
Why?
|
| Retreatment | 4 | 2017 | 89 | 0.200 |
Why?
|
| Triiodobenzoic Acids | 2 | 2020 | 31 | 0.200 |
Why?
|
| Critical Illness | 1 | 2007 | 601 | 0.200 |
Why?
|
| Recurrence | 5 | 2019 | 1394 | 0.200 |
Why?
|
| DiGeorge Syndrome | 1 | 2023 | 80 | 0.190 |
Why?
|
| Placenta Diseases | 1 | 2022 | 59 | 0.190 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2022 | 62 | 0.190 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2020 | 763 | 0.190 |
Why?
|
| Magnetic Resonance Imaging, Cine | 5 | 2023 | 160 | 0.190 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2021 | 242 | 0.190 |
Why?
|
| Patient Care Team | 2 | 2024 | 545 | 0.190 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 1 | 2022 | 16 | 0.190 |
Why?
|
| Electrocoagulation | 2 | 2023 | 35 | 0.190 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2022 | 18 | 0.190 |
Why?
|
| Hemangioma | 1 | 2022 | 94 | 0.180 |
Why?
|
| Child Development | 2 | 2024 | 268 | 0.180 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2022 | 68 | 0.180 |
Why?
|
| Postoperative Period | 2 | 2020 | 335 | 0.180 |
Why?
|
| Hypertension, Portal | 1 | 2022 | 78 | 0.180 |
Why?
|
| Vocal Cord Paralysis | 1 | 2022 | 67 | 0.180 |
Why?
|
| Coronary Thrombosis | 1 | 2021 | 35 | 0.180 |
Why?
|
| Coronary Sinus | 1 | 2021 | 14 | 0.180 |
Why?
|
| Comparative Effectiveness Research | 1 | 2021 | 68 | 0.180 |
Why?
|
| Risk Adjustment | 1 | 2021 | 58 | 0.180 |
Why?
|
| Fistula | 1 | 2021 | 49 | 0.170 |
Why?
|
| Patient Care Management | 1 | 2021 | 67 | 0.170 |
Why?
|
| Hemoptysis | 1 | 2020 | 22 | 0.170 |
Why?
|
| Aortic Valve Stenosis | 2 | 2019 | 338 | 0.170 |
Why?
|
| Heart Injuries | 1 | 2020 | 46 | 0.170 |
Why?
|
| Exercise Test | 4 | 2024 | 254 | 0.170 |
Why?
|
| Infant, Low Birth Weight | 1 | 2021 | 167 | 0.170 |
Why?
|
| Heart Septal Defects | 1 | 2020 | 38 | 0.170 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2020 | 21 | 0.170 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 2913 | 0.170 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 49 | 0.170 |
Why?
|
| Fetal Diseases | 1 | 2024 | 456 | 0.170 |
Why?
|
| Conservative Treatment | 1 | 2020 | 36 | 0.160 |
Why?
|
| Health Care Rationing | 1 | 2020 | 58 | 0.160 |
Why?
|
| Feeding Methods | 1 | 2019 | 37 | 0.160 |
Why?
|
| Body Surface Area | 1 | 2019 | 31 | 0.160 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 129 | 0.160 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2019 | 38 | 0.160 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 29 | 0.160 |
Why?
|
| Patients | 1 | 2020 | 120 | 0.160 |
Why?
|
| Liver Transplantation | 2 | 2019 | 1043 | 0.160 |
Why?
|
| Punctures | 4 | 2019 | 55 | 0.160 |
Why?
|
| Contrast Media | 2 | 2020 | 480 | 0.150 |
Why?
|
| Patient Positioning | 1 | 2019 | 55 | 0.150 |
Why?
|
| Femoral Artery | 1 | 2019 | 182 | 0.150 |
Why?
|
| Phlebography | 2 | 2016 | 43 | 0.150 |
Why?
|
| Metals | 1 | 2019 | 64 | 0.150 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2019 | 83 | 0.150 |
Why?
|
| Heart Septum | 1 | 2018 | 54 | 0.150 |
Why?
|
| Upper Extremity | 1 | 2019 | 53 | 0.150 |
Why?
|
| Aortography | 2 | 2016 | 190 | 0.150 |
Why?
|
| Hemodynamic Monitoring | 1 | 2018 | 12 | 0.150 |
Why?
|
| Hypertension, Renovascular | 1 | 2018 | 29 | 0.150 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 84 | 0.150 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2019 | 118 | 0.150 |
Why?
|
| Sinus of Valsalva | 1 | 2018 | 35 | 0.150 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 730 | 0.150 |
Why?
|
| Prognosis | 4 | 2020 | 4691 | 0.150 |
Why?
|
| Renal Artery Obstruction | 1 | 2018 | 39 | 0.140 |
Why?
|
| Ventricular Function | 1 | 2018 | 91 | 0.140 |
Why?
|
| Heart | 2 | 2023 | 731 | 0.140 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2018 | 93 | 0.140 |
Why?
|
| Hospital Costs | 1 | 2019 | 180 | 0.140 |
Why?
|
| Atrial Septum | 1 | 2017 | 10 | 0.140 |
Why?
|
| Physical Exertion | 1 | 2017 | 78 | 0.140 |
Why?
|
| Parents | 1 | 2024 | 1024 | 0.140 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2017 | 21 | 0.140 |
Why?
|
| Hemodiafiltration | 1 | 2017 | 18 | 0.140 |
Why?
|
| Radiography, Interventional | 3 | 2017 | 81 | 0.140 |
Why?
|
| Jugular Veins | 1 | 2017 | 76 | 0.140 |
Why?
|
| Tennessee | 1 | 2016 | 27 | 0.130 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 193 | 0.130 |
Why?
|
| Equipment Failure | 1 | 2017 | 121 | 0.130 |
Why?
|
| Computer Simulation | 1 | 2020 | 654 | 0.130 |
Why?
|
| Chest Pain | 1 | 2017 | 129 | 0.130 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2018 | 521 | 0.130 |
Why?
|
| Comorbidity | 2 | 2019 | 1532 | 0.130 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2017 | 254 | 0.130 |
Why?
|
| Infant Mortality | 1 | 2017 | 176 | 0.130 |
Why?
|
| Osteosarcoma | 1 | 2019 | 255 | 0.130 |
Why?
|
| Radiation Dosage | 2 | 2019 | 135 | 0.130 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 1043 | 0.130 |
Why?
|
| Vascular Diseases | 1 | 2018 | 155 | 0.130 |
Why?
|
| Steroid Metabolism, Inborn Errors | 1 | 2015 | 3 | 0.130 |
Why?
|
| Cholic Acids | 1 | 2015 | 16 | 0.130 |
Why?
|
| Communication | 1 | 2020 | 515 | 0.120 |
Why?
|
| Developmental Disabilities | 2 | 2024 | 715 | 0.120 |
Why?
|
| Acute Disease | 1 | 2018 | 1096 | 0.120 |
Why?
|
| Transition to Adult Care | 1 | 2017 | 118 | 0.120 |
Why?
|
| Tomography, Optical Coherence | 2 | 2017 | 522 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2017 | 195 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 645 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 631 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2015 | 79 | 0.120 |
Why?
|
| Research Design | 1 | 2019 | 694 | 0.120 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 139 | 0.120 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2016 | 224 | 0.120 |
Why?
|
| Birth Weight | 1 | 2016 | 346 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 239 | 0.120 |
Why?
|
| Balloon Occlusion | 1 | 2015 | 46 | 0.120 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 427 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 362 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 378 | 0.110 |
Why?
|
| Aged | 11 | 2019 | 19747 | 0.110 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 192 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 1097 | 0.110 |
Why?
|
| Cardiology | 1 | 2019 | 507 | 0.110 |
Why?
|
| Length of Stay | 4 | 2023 | 1313 | 0.110 |
Why?
|
| Gene Duplication | 1 | 2015 | 363 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1334 | 0.100 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2012 | 133 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 2 | 2025 | 275 | 0.100 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2013 | 47 | 0.100 |
Why?
|
| Patient Safety | 1 | 2017 | 398 | 0.100 |
Why?
|
| Gestational Age | 1 | 2016 | 1169 | 0.100 |
Why?
|
| Stroke Volume | 1 | 2014 | 496 | 0.090 |
Why?
|
| Quality of Life | 1 | 2021 | 1949 | 0.090 |
Why?
|
| Anesthesia, General | 1 | 2011 | 118 | 0.090 |
Why?
|
| Hirudins | 1 | 2011 | 37 | 0.090 |
Why?
|
| Anticoagulants | 3 | 2011 | 578 | 0.090 |
Why?
|
| Sarcoma | 1 | 2012 | 184 | 0.080 |
Why?
|
| Databases, Factual | 3 | 2020 | 1174 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 886 | 0.080 |
Why?
|
| Aortic Diseases | 1 | 2011 | 197 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 373 | 0.080 |
Why?
|
| Intracranial Embolism | 1 | 2008 | 27 | 0.080 |
Why?
|
| Preliminary Data | 2 | 2018 | 7 | 0.080 |
Why?
|
| Receptors, LDL | 2 | 2019 | 88 | 0.070 |
Why?
|
| Stroke | 3 | 2012 | 981 | 0.070 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 290 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2011 | 781 | 0.070 |
Why?
|
| Electrocardiography | 3 | 2021 | 978 | 0.060 |
Why?
|
| Morbidity | 2 | 2021 | 248 | 0.060 |
Why?
|
| Sex Chromosome Disorders | 1 | 2004 | 8 | 0.060 |
Why?
|
| Observational Studies as Topic | 1 | 2025 | 88 | 0.060 |
Why?
|
| Monosomy | 1 | 2004 | 24 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 1065 | 0.060 |
Why?
|
| Executive Function | 1 | 2024 | 111 | 0.050 |
Why?
|
| Tomography, Spiral Computed | 1 | 2003 | 16 | 0.050 |
Why?
|
| Algorithms | 2 | 2020 | 1633 | 0.050 |
Why?
|
| Pandemics | 2 | 2021 | 1113 | 0.050 |
Why?
|
| Mosaicism | 1 | 2004 | 239 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2012 | 354 | 0.050 |
Why?
|
| Hydrops Fetalis | 1 | 2022 | 74 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 86 | 0.050 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 473 | 0.050 |
Why?
|
| Viridans Streptococci | 1 | 2021 | 8 | 0.050 |
Why?
|
| Portal Vein | 1 | 2022 | 92 | 0.050 |
Why?
|
| Ascites | 1 | 2022 | 93 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2023 | 353 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 700 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 2 | 2012 | 57 | 0.040 |
Why?
|
| International Cooperation | 1 | 2021 | 157 | 0.040 |
Why?
|
| Arteries | 1 | 2021 | 218 | 0.040 |
Why?
|
| Collateral Circulation | 2 | 2012 | 41 | 0.040 |
Why?
|
| Resource Allocation | 1 | 2020 | 52 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 230 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 206 | 0.040 |
Why?
|
| Ohio | 1 | 2019 | 87 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 54 | 0.040 |
Why?
|
| Pacemaker, Artificial | 1 | 2022 | 174 | 0.040 |
Why?
|
| Ireland | 1 | 2019 | 28 | 0.040 |
Why?
|
| Defibrillators, Implantable | 1 | 2022 | 190 | 0.040 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2024 | 501 | 0.040 |
Why?
|
| Models, Economic | 1 | 2019 | 51 | 0.040 |
Why?
|
| Pulmonary Ventilation | 1 | 2019 | 29 | 0.040 |
Why?
|
| Extracellular Space | 1 | 1999 | 87 | 0.040 |
Why?
|
| Cost Savings | 1 | 2019 | 71 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 399 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2019 | 90 | 0.040 |
Why?
|
| Disease Progression | 1 | 2025 | 2083 | 0.040 |
Why?
|
| Mitral Valve Stenosis | 1 | 2018 | 36 | 0.040 |
Why?
|
| Age Distribution | 1 | 2019 | 418 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 57 | 0.040 |
Why?
|
| Placenta | 1 | 2022 | 508 | 0.040 |
Why?
|
| Operative Time | 1 | 2019 | 165 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2019 | 103 | 0.040 |
Why?
|
| Program Development | 1 | 2019 | 185 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 463 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 316 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 305 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 220 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 178 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 462 | 0.040 |
Why?
|
| Michigan | 1 | 2017 | 42 | 0.040 |
Why?
|
| Iohexol | 1 | 2017 | 21 | 0.040 |
Why?
|
| Needles | 1 | 2017 | 51 | 0.030 |
Why?
|
| Replantation | 1 | 2017 | 55 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 441 | 0.030 |
Why?
|
| Weight Gain | 1 | 2019 | 400 | 0.030 |
Why?
|
| Telemetry | 1 | 2016 | 28 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 175 | 0.030 |
Why?
|
| Drainage | 1 | 2018 | 260 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 477 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 705 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 511 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 291 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 237 | 0.030 |
Why?
|
| Hypertension | 2 | 2019 | 1332 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 516 | 0.030 |
Why?
|
| Cattle | 1 | 2017 | 567 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2020 | 479 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1609 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 586 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2016 | 145 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 1999 | 488 | 0.030 |
Why?
|
| GATA4 Transcription Factor | 1 | 2015 | 40 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 595 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 859 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 880 | 0.030 |
Why?
|
| Decision Making | 1 | 2020 | 657 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1253 | 0.030 |
Why?
|
| Calcium | 1 | 1999 | 1105 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1430 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1808 | 0.030 |
Why?
|
| Hematologic Agents | 1 | 2012 | 6 | 0.030 |
Why?
|
| Off-Label Use | 1 | 2012 | 28 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2057 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6559 | 0.020 |
Why?
|
| Syndrome | 1 | 2015 | 1122 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1361 | 0.020 |
Why?
|
| Sternotomy | 1 | 2012 | 42 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2015 | 652 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2012 | 54 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 876 | 0.020 |
Why?
|
| Herniorrhaphy | 1 | 2011 | 81 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2012 | 195 | 0.020 |
Why?
|
| DNA | 1 | 2015 | 1619 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2009 | 73 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 150 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2009 | 126 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1282 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2009 | 171 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 1119 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 164 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2011 | 467 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 759 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1400 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 1494 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2004 | 49 | 0.010 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2004 | 22 | 0.010 |
Why?
|
| Chromosomes, Human, X | 1 | 2004 | 158 | 0.010 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2003 | 42 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 1049 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2003 | 239 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 2469 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 5903 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2004 | 515 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 34309 | 0.010 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 1999 | 7 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 262 | 0.010 |
Why?
|
| Parietal Cells, Gastric | 1 | 1999 | 38 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 136 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 463 | 0.010 |
Why?
|
| Stomach | 1 | 1999 | 270 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 1293 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 1242 | 0.010 |
Why?
|
| RNA | 1 | 1999 | 574 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 1703 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 3109 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 3897 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 1705 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1999 | 3043 | 0.010 |
Why?
|
| Rats | 1 | 1999 | 3727 | 0.010 |
Why?
|